ReviewACS nano2024
Mass Production of Graphene Oxide Beyond the Laboratory: Bridging the Gap Between Academic Research and Industry.
Review in ACS nano, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Degradable biophotonic scaffolds of mesoporous graphene for regenerating neural pathways.Journal of materials science. Materials in medicine · 2026Article
- Synthesis and Characterization of CNC/CNF/rGO Composite Films for Advanced Functional Applications.Micromachines · 2026Article
- Water-Resistant Antibacterial Coatings Using Cetylpyridinium Chloride - Graphene Oxide Composites.ACS omega · 2026Article
- Investigation of Measurement Cycle Reproducibility and Dynamic Resistance-Switching Capability in Reduced Graphene Oxide.ACS omega · 2026Article
- Graphene oxide synthesis at a nonthermal plasma-water interface.Nature communications · 2026Article
- Response to multigenerational graphene oxide exposure in acheta domesticus strains selected for longevity.Scientific reports · 2026Article
- Revolutionizing cancer treatment: The multifaceted role of graphene oxide in modern oncology.Bioengineering & translational medicine · 2026Review
- Quantum Transport and Molecular Sensing in Reduced Graphene Oxide Measured with Scanning Probe Microscopy.Molecules (Basel, Switzerland) · 2025Article
- Exploring 2D Graphene-Based Nanomaterials for Biomedical Applications: A Theoretical Modeling Perspective.Small science · 2025Article
- Performance Assessment of Graphene Oxide as a Protective Coating for Historical Stone.Materials (Basel, Switzerland) · 2025Article
- Unveiling the Role of Fractionated Graphene Oxide in Nitric Oxide Scavenging.Molecules (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The mass production of graphene oxide (GO) has garnered significant attention in recent years due to its potential applications in various fields, from materials science to biomedicine. Graphene, known for its unique properties, such as high conductivity and mechanical strength, has been extensively studied. However, traditional production methods such as the exfoliation of graphite with scotch tape are not suitable for large-scale production. This has led to an increased focus on GO as a viable alternative to graphene production. Nonetheless, challenges, including the optimization of oxidation processes, the control of structural uniformity, and the reproducibility of production, have not been solved so far. This review critically examines GO production advancements by analyzing experimental and mechanistic studies to identify significant developments that enable high-yield and reproducible methods suitable for industrial-scale production. Special attention is given to oxidation techniques and postsynthesis purification and storage, with a focus on controlled oxidation to achieve homogeneous and single-layer GO. Through this lens, the review outlines the path forward for the industrialization of GO, aiming to bridge the gap between academic research and industrial production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.